drugset / Trial / NCT00210899
Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril versus a comparator in the treatment of patients with complicated skin and skin structure infections. The study will also characterize the safety and tolerability of treatment with ceftobiprole medocaril in patients with complicated skin and skin structure infections.
Timeline
- Start
- 2005-09
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ceftazidime | Small molecule | 1 g | — |
| Subject | Ceftobiprole medocaril | Small molecule | 500 mg | — |
| Comparator | Vancomycin | Other / unclassified | 1 g | — |